Characterizing the Binding of Angiotensin Converting Enzyme I Inhibitory Peptide to Human Hemoglobin: Influence of Electromagnetic Fields

Protein Pept Lett. 2020;27(10):1007-1021. doi: 10.2174/1871530320666200425203636.

Abstract

Background: Drug-protein complexes is one of the crucial factors when analyzing the pharmacokinetics and pharmacodynamics of a drug because they can affect the excretion, distribution, metabolism and interaction with target tissues.

Objectives: The aim of this study was to investigate the interaction of human hemoglobin (Hb) and angiotensin I converting enzyme inhibitory peptide (ACEIP) in the absence and presence of different- frequency electromagnetic fields (EMF).

Methods: Various spectroscopic methods like fluorescence spectroscopy, ultraviolet, circular dichroism and conductometry techniques were applied to investigate Hb-ACEIP interaction in the absence and presence of EMF.

Result: The presented spectroscopic studies indicated that EMF changed the interaction between Hb and ACEIP. The a-helix content of Hb decreased upon binding to ACEIP and conductivity of the solution enhanced upon binding. Based on Stern-Volmer equations, it could be stated that the Hb-ACEIP affinity was higher in the presence of EMF.

Conclusion: It can be concluded that for patients who use the drug to control blood pressure, a low-frequency electromagnetic field would have a positive effect on the uptake of the drug.

Keywords: ACE inhibitory peptide; Drug-protein complexes; circular dichroism; electromagnetic field; fluorescence spectroscopy; human hemoglobin.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / chemistry*
  • Electromagnetic Fields*
  • Hemoglobins / chemistry*
  • Humans
  • Peptides / chemistry*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Hemoglobins
  • Peptides